Current and evolving features in the clinical management of haemophilia.
作者信息
Coppola Antonio, Morfini Massimo, Cimino Ernesto, Tufano Antonella, Cerbone Anna M, Di Minno Giovanni
机构信息
Regional Reference Centre for Bleeding Disorders, Federico II University Hospital, Naples, Italy.
Italian Association of Haemophilia Centres (AICE), Florence, Italy.
出版信息
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s554-62. doi: 10.2450/2014.0043-14s.
Abstract
摘要
相似文献
1
Current and evolving features in the clinical management of haemophilia.血友病临床管理中的当前及不断演变的特征
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s554-62. doi: 10.2450/2014.0043-14s.
2
The haemophilia certification system in Canada.加拿大的血友病认证系统。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):e531-41. doi: 10.2450/2014.0032-14s.
3
Uncovered needs in the management of inherited bleeding disorders in Italy.意大利遗传性出血性疾病管理中未被满足的需求。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s563-6. doi: 10.2450/2014.0036-14s.
4
Methodology for the development of the NHF-McMaster Guideline on Care Models for Haemophilia Management.加拿大血友病基金会-麦克马斯特血友病管理护理模式指南制定方法。
Haemophilia. 2016 Jul;22 Suppl 3:17-22. doi: 10.1111/hae.13007.
5
Hemophilia comprehensive care model waiting to be duplicated for other rare chronic conditions.血友病综合护理模式有待在其他罕见慢性病中推广应用。
Transfus Apher Sci. 2013 Apr;48(2):119-21. doi: 10.1016/j.transci.2013.02.036.
6
Common themes and challenges in hemophilia care: a multinational perspective.血友病护理中的常见主题与挑战：跨国视角
Hematology. 2019 Dec;24(1):39-48. doi: 10.1080/10245332.2018.1505225. Epub 2018 Aug 3.
7
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?血友病中心认证系统：医疗系统的可选还是最佳选择？
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s492-4. doi: 10.2450/2014.0076-14s.
8
Haemophilia Centre certification system across Europe: the Belgian experience.欧洲血友病中心认证系统：比利时的经验。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s497-500. doi: 10.2450/2014.0061-14s.
9
Quality of haemophilia care in The Netherlands: new standards for optimal care.荷兰血友病护理质量：最佳护理新标准
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s501-4. doi: 10.2450/2014.0041-14s.
10
The methodology for defining the European standards for the certification of Haemophilia Centres in Europe.欧洲血友病中心认证的欧洲标准定义方法。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s519-24. doi: 10.2450/2014.0046-14s.
引用本文的文献
1
Use of Continuous Veno-Venous Hemodialysis (CVVHD) in Treatment of a Polytrauma Patient with Severe Hemophilia A.连续性静脉-静脉血液透析（CVVHD）在治疗严重甲型血友病多发创伤患者中的应用。
Am J Case Rep. 2022 Mar 21;23:e934802. doi: 10.12659/AJCR.934802.
2
Management of Hemophilia in Older Patients.老年血友病患者的管理
Drugs Aging. 2017 Dec;34(12):881-889. doi: 10.1007/s40266-017-0500-8.
3
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?血友病中心认证系统：医疗系统的可选还是最佳选择？
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s492-4. doi: 10.2450/2014.0076-14s.
本文引用的文献
1
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.意大利血友病治疗者对方案和产品选择的认知挑战和态度：2013 年 AICE 调查。
Haemophilia. 2014 Mar;20(2):e128-35. doi: 10.1111/hae.12334.
2
Molecular approaches for improved clotting factors for hemophilia.用于提高血友病凝血因子的分子方法。
Blood. 2013 Nov 21;122(22):3568-74. doi: 10.1182/blood-2013-07-498261. Epub 2013 Sep 24.
3
Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.出血性疾病长期治疗的病原体安全性：（不可）预测的风险和不断演变的威胁。
Semin Thromb Hemost. 2013 Oct;39(7):779-93. doi: 10.1055/s-0033-1354420. Epub 2013 Sep 12.
4
Tailored versus standard dose prophylaxis in children with hemophilia A.血友病 A 患儿的个体化与标准剂量预防治疗。
Semin Thromb Hemost. 2013 Oct;39(7):711-22. doi: 10.1055/s-0033-1354419. Epub 2013 Sep 10.
5
Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update.系统评价 FVIII 浓缩物在既往未治疗的重度血友病 A 患者抑制剂发展中的作用：2013 年更新。
Semin Thromb Hemost. 2013 Oct;39(7):752-66. doi: 10.1055/s-0033-1356715. Epub 2013 Sep 10.
6
Hemophilia a and hemophilia B: different types of diseases?血友病 A 和血友病 B：不同类型的疾病？
Semin Thromb Hemost. 2013 Oct;39(7):697-701. doi: 10.1055/s-0033-1353996. Epub 2013 Sep 8.
7
Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities.综合性血友病护理中的新问题：预防、识别和监测与年龄相关的合并症。
Semin Thromb Hemost. 2013 Oct;39(7):794-802. doi: 10.1055/s-0033-1354424. Epub 2013 Sep 8.
8
Future of coagulation factor replacement therapy.凝血因子替代治疗的未来。
J Thromb Haemost. 2013 Jun;11 Suppl 1:84-98. doi: 10.1111/jth.12270.
9
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.血友病伴抑制物患者应用抗抑制物复合物浓缩物预防治疗的健康相关生活质量：Pro-FEIBA 研究结果。
Haemophilia. 2013 Sep;19(5):736-43. doi: 10.1111/hae.12178. Epub 2013 Jun 4.
10
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.VIII 因子治疗强度与严重 A 型血友病儿童抑制剂发展：RODIN 研究。
Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3.
Zotero 插件